VERQUVO

Bayer Inc🇨🇦 Health Canada

Approval Id: 8a6fda8495701cf7
Drug Approval Canada Name: VERQUVO
Product Name: VERQUVO
Status: Marketed
Status Date: 2023-09-19
Original Market Date: 2023-09-19
Din: 02537044
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 24:08.10
Atc Original: C01DX22 VERICIGUAT
Atc Name: c 01 dx 22
Aig Number: 0164541001
Company Name: Bayer Inc
Company Address: 2920 Matheson Blvd East, Mississauga, Ontario, Canada, L4W 5R6

VERICIGUAT

2.5 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

8a6fda8495701cf7

Type

Standard